App aims to get breast cancer patients moving during chemo

NCT ID NCT03674515

Terminated Symptom relief Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a smartphone app called 'Bouge' to see if it could help women with non-metastatic breast cancer increase their daily steps while on weekly Taxol chemotherapy. The goal was to add 3,000 steps per day over 90 days. Only 23 people enrolled, and the trial was stopped early, so we cannot draw firm conclusions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: smartphone application
What this could lead to: If it worked, this could show that a simple app helps breast cancer patients stay active during chemotherapy.
What could go wrong: The trial was terminated early and had only 23 participants, so results are very limited. It is unclear if the app truly improves physical activity or well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER MOBILE HEALTH APPS PHYSICAL ACTIVITY

Contacts and locations

Locations

CHRU de Brest

Brest, Brest, 29609, France
CHU de Morlaix

Morlaix, Morlaix, 29200, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.